23 Jul

GlaxoSmithKline Considers Consumer Business Spin-Off, Stock Up

WRITTEN BY Sarah Collins

GSK stock rose on Friday

On Friday, July 20, GlaxoSmithKline (GSK) stock rose ~2.9% to close at $41.87. The stock was trending upward on the news by the Financial Times that the board is considering splitting the company. The report also announced that the chairman is discussing spinning off the consumer division on continued pressure from investors.

GlaxoSmithKline Considers Consumer Business Spin-Off, Stock Up

As per the Financial Times report, GlaxoSmithKline chairman Philip Hampton is discussing establishing a standalone pharma and vaccine company over the next two to three years. Investors believe the company’s pharma and consumer businesses have limited synergies. On June 1, GlaxoSmithKline completed the buyout of Novartis’s stake in their consumer healthcare joint venture and took full ownership of the business for $13 billion.

Also on Friday, GlaxoSmithKline received FDA approval for its malaria relapse drug Krintafel (tafenoquine). The drug is the first new treatment approved for plasmodium vivax malaria in over 60 years.

GlaxoSmithKline is slated to announce its Q2 2018 earnings results on July 25. Wall Street expects the company to report sales of $9.7 billion, representing year-over-year growth of ~3.5%.

Analysts’ recommendations for GSK stock

As of July 23, GSK stock has a consensus analyst target price of $42.13, which implies a return potential of ~2.5% over the next 12 months. As per a recent Reuters survey comprising five analysts covering GSK stock, only one analyst has a “strong buy” rating on the stock while the rest have “hold” ratings.

Check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!

Latest articles

In Q3, billionaire investor Leon Cooperman's top five holdings were Fiserv, Alphabet, United Continental, Chimera Investment, and Cigna.

In 2018, 3,503 metric tons of gold were produced globally, 1.8% higher than in 2017. Let's look at the world's top gold-producing countries.

TJX Companies (TJX) reported better-than-expected earnings results for the third quarter of fiscal 2020, which ended on November 2.

Despite Canada's legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.

On November 11, the NHS (National Health Service) approved two cannabis-based medicines, Epidyolex and Sativex, for use in the United Kingdom.

Roku (ROKU) stock tanked more than 5% on Tuesday during market hours. The company said it will issue nearly 1 million common shares today.